Condition deep-dive · 6 min read

Hemorrhoid supplement adjunct — flavonoids, fibre, and what actually helps

Updated 2026-05-16 · Reviewed by SupplementScore editors · No sponsorships

Hemorrhoidal disease — symptomatic dilation of the anal vascular cushions — is one of the most common GI complaints, with lifetime prevalence around 40%. The supplement layer that has clinical-trial evidence is narrow: micronised purified flavonoid fraction (MPFF, the diosmin/hesperidin combination) for bleeding and acute attacks, plus fibre (psyllium) to soften stool and reduce straining. Most other "hemorrhoid relief" products are local soothing agents (witch hazel pads, lidocaine creams) which have their place but are different from systemic supplements. The behavioural foundation — fibre, hydration, toilet behaviour, and not over-wiping — matters more than any pill.

Read this first. Rectal bleeding deserves clinical assessment — particularly first-onset bleeding, bleeding in someone over 50 without prior colonoscopy, change in pattern, bleeding with weight loss or anemia, or persistent bleeding despite hemorrhoid management. Colorectal cancer can present as "hemorrhoidal" bleeding. Severe pain (acute thrombosed hemorrhoid), prolapse that doesn't reduce, or signs of strangulation warrant prompt evaluation. The supplement layer is adjunct to clinical care, not a substitute.

What has trial evidence

Tier 1 evidence · Acute and recurrent bleeding

Micronised purified flavonoid fraction (MPFF — diosmin 90% + hesperidin 10%)

Acute attack: 2 tablets t.i.d. × 4 days, then 2 tablets b.i.d. × 3 days. Maintenance: 2 tablets/day for 2 months.

Cochrane review (Alonso-Coello 2006) of MPFF in hemorrhoidal disease shows clinically meaningful reductions in bleeding, anal discomfort, and recurrence. Pharmacologically, MPFF improves venous tone, reduces capillary fragility, and has mild anti-inflammatory action. Standard initial use during acute symptomatic attack with maintenance for 2 months. Widely used in Europe and South America; less prominent in US OTC channels but available as Daflon and generic diosmin/hesperidin formulations.

Tier 1 evidence · Stool transit and straining reduction

Psyllium husk

3.5 g (≈1 rounded teaspoon) 1–3× daily, with ≥240 mL water per dose

Cochrane and AGA evidence-based guidelines support fibre supplementation in hemorrhoidal disease for reducing symptoms and recurrence. Psyllium has the most consistent evidence among soluble fibre options. Start at 1 dose/day and titrate to 2–3/day over 2 weeks (going too fast causes bloating and gas). Adequate water is essential — psyllium without enough water worsens constipation. Effect on bleeding and discomfort develops over 2–4 weeks.

Tier 2 evidence · Venotonic adjunct

Diosmin (standalone, semi-synthetic)

500 mg b.i.d. (1000 mg/day)

Diosmin is the dominant active in MPFF; standalone diosmin preparations (Vasculera, generic 500 mg tablets) are widely available. Trials of standalone diosmin show similar venotonic effects to MPFF, though MPFF micronisation improves bioavailability and the head-to-head trials slightly favor MPFF. A reasonable substitute where MPFF specifically isn't available.

Tier 2 evidence · Pregnancy-related hemorrhoids

Horse chestnut (Aesculus hippocastanum, escin-standardised)

300–600 mg/day standardised to 50 mg escin daily

Most evidence is in chronic venous insufficiency (Cochrane review supports a modest effect on lower-limb venous symptoms). Hemorrhoidal-specific data is smaller but supportive. Caution: bleeding risk with anticoagulants; discuss with prescriber. Avoid in pregnancy unless under obstetric guidance.

The behavioural foundation — typically higher yield than supplements

Several behavioural and dietary interventions usually produce larger improvements than any pill:

Fibre target of 25–35 g/day — prioritise food first (psyllium tops up the gap, doesn't replace dietary fibre).
Adequate hydration — 1.5–2 L/day of fluid; fibre without water worsens constipation.
Toilet behaviour — don't sit on the toilet reading; toilet posture (squatty potty / footstool) reduces straining; respond to urge promptly.
Avoid prolonged sitting — particularly on the toilet; brief sits, not long ones.
Limit straining — if stool is not coming out easily, get off the toilet and try again later.
Sitz baths — warm-water sitz baths 10–15 minutes 2–3× daily during acute flares; significantly reduces discomfort.
Avoid over-wiping — soft, unscented wipes or peri-bottle rinse; pat dry; harsh wiping perpetuates irritation.
Weight management and exercise — both reduce intra-abdominal pressure; sedentary patterns worsen.
Topical adjuncts during flares — witch hazel pads, hydrocortisone 1% short-term for inflammation, lidocaine for acute pain (short-term only).

What to skip

Chronic stimulant laxatives (senna, bisacodyl) — for hemorrhoids, you want softer stool, not more forceful bowel motility; chronic stimulants can worsen straining when they wear off.
Mineral oil — interferes with fat-soluble vitamin absorption and risks aspiration in older adults; better fibre options exist.
"Hemorrhoid relief" multi-ingredient OTC pills with proprietary blends — sub-therapeutic doses and untested combinations; pay for MPFF and fibre instead.
Long-term topical hydrocortisone — local cortisone for >1–2 weeks can cause skin thinning and dependence.
Phenylephrine-containing "Preparation H" for prolapse reduction — vasoconstrictor; not appropriate in users with hypertension, cardiovascular disease, or on MAOIs.

What to track

Symptom diary: bleeding frequency, pain on defecation (0–10), prolapse, post-defecation discomfort, dietary fibre intake, water intake, time spent on toilet. The Hemorrhoid Severity Score (HSS) or simpler ranking is reasonable for self-tracking. Reassess at 4 weeks of supplement use. If bleeding is not resolving with maintenance MPFF + adequate fibre, escalate to surgical or procedural evaluation (rubber band ligation, sclerotherapy, hemorrhoidectomy for higher grades).

Practical quick-start. Address the behavioural foundation first — fibre target, hydration, toilet behaviour, sitz baths during flares. During an acute symptomatic attack with bleeding or pain: start MPFF (Daflon) at the acute-attack regimen for 7 days, then maintenance 1000 mg/day for 2 months. Layer in psyllium 3.5 g once daily, titrating to 2–3×/day over 2 weeks. Recurrent flares, persistent bleeding, or prolapse not responding to this protocol warrant clinical evaluation and procedural treatment.

Educational reference, not medical advice. Rectal bleeding requires clinical evaluation to rule out colorectal cancer, particularly in users over 50 or with new-onset symptoms. Discuss any supplement change with a qualified clinician.